A Theranostic Nanorobotic Platform for Cancer: Integrating Smart Nanomaterials and Biological Computers into Tumor Microenvironment-Responsive Systems

Abstract

Conventional nanomedicine approaches for cancer therapy face a fundamental limitation: they lack the capacity for autonomous sensing and decision-making, rendering them incapable of adapting to the dynamic and heterogeneous nature of the tumor microenvironment (TME). This review presents a comprehensive framework for a next-generation theranostic nanorobot that integrates three transformative technologies: DNA origami for structural precision, nucleic acid-based logic gates for onboard computing, and externally actuated propulsion systems for targeted navigation. We propose a closed-loop architecture wherein the nanorobot senses multiple TME biomarkers—including pH, enzymatic activity, and hypoxia—processes these inputs through Boolean logic operations (AND/OR gates), and executes therapeutic actions exclusively upon satisfaction of predefined criteria. This paradigm shifts from passive accumulation to active computation, enabling unprecedented specificity in tumor targeting. We critically examine recent advances in DNA nanotechnology for logic-gated molecular systems, magnetic and acoustic actuation platforms for in vivo navigation, and optoacoustic imaging modalities for real-time tracking. Key challenges addressed include biocompatibility, bioenergetics for autonomous function, and integration of synthetic biology tools for metabolic support. Finally, we envision a future "sense-compute-respond" platform that embodies the convergence of nanobiotechnology, systems biology, and precision medicine.